JP5315056B2
(ja )
2013-10-16
固結抑制粒状製剤
EP0966969A4
(en )
2000-04-26
ANTI-STRESS ACTIVE AND FUNCTIONAL NUTRIENTS WITH ANTI-STRESS EFFECTS
UA95828C2
(ru )
2011-09-12
Твердая рецептура, которая содержит алоглиптин и пиоглитазон
WO2007067582A3
(en )
2007-08-02
Process for manufacturing chewable dosage forms for drug delivery and products thereof
CN117412747A
(zh )
2024-01-16
用于治疗激越的方法和组合物
WO2007009806A3
(en )
2007-04-05
Solid dosage formulations of narcotic drugs having improved buccal adsorption
JP2011506587A5
(https= )
2012-02-16
ES2940822T3
(es )
2023-05-11
Agente elevador de la concentración de óxido nítrico
WO2007014124A3
(en )
2007-10-04
High drug load formulations and dosage forms
WO2007144083A3
(de )
2008-04-17
Ache-nmda-kombinationswafer
JP2007517039A5
(https= )
2008-02-21
Singh et al.
2012
An overview on fast disintegrating sublingual tablets
JP2018039810A5
(https= )
2018-05-17
GB2443793B
(en )
2010-12-01
Product, method of manufacture and use
JP2007290977A5
(https= )
2009-02-19
KR20130113348A
(ko )
2013-10-15
미립자 코팅 제제
RU2686694C2
(ru )
2019-04-30
Комбинированный лекарственный препарат в форме шипучих таблеток и способ его получения
WO2004096125A3
(en )
2004-12-23
Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem
WO2004004705A3
(en )
2004-03-11
Pharmaceutical formulations for preparing drink products
JP2006265231A5
(https= )
2009-02-19
JP2011079789A
(ja )
2011-04-21
アンジオテンシンi変換酵素阻害剤
JP2011136932A
(ja )
2011-07-14
脳機能改善用組成物および脳機能を改善する方法
WO2005115346A3
(en )
2006-07-06
Pharmaceutical composition containing risperidone
ATE457721T1
(de )
2010-03-15
An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen
WO2003026621A3
(fr )
2003-10-09
Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu